Cargando…
Paclitaxel inhibits the migration of CD133+ U251 malignant glioma cells by reducing the expression of glycolytic enzymes
Energy metabolic reprogramming (EMR) allows for the rearrangement of a series of metabolic genes and proteins when tumor cells adapt to their microenvironment. EMR is characterized by changes in the metabolic pattern and metabolic intermediates to meet the needs of tumor cells for their malignant pr...
Autores principales: | Long, Niya, Peng, Shuo, Chu, Liangzhao, Jia, Jun, Dong, Minghao, Liu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490788/ https://www.ncbi.nlm.nih.gov/pubmed/32963602 http://dx.doi.org/10.3892/etm.2020.9200 |
Ejemplares similares
-
Screening glioma stem cells in U251 cells based on the P1 promoter of the CD133 gene
por: Wang, Xiaofeng, et al.
Publicado: (2016) -
Effect of siRNA-Livin on drug resistance to chemotherapy in glioma U251 cells and CD133(+) stem cells
por: LIU, YANG, et al.
Publicado: (2015) -
Effects of syndecan-1 on the expression of syntenin and the migration of U251 glioma cells
por: Chen, Jun, et al.
Publicado: (2017) -
Increased chemotactic migration and growth in heparanase-overexpressing human U251n glioma cells
por: Hong, Xin, et al.
Publicado: (2008) -
INHIBITION OF PACLITAXEL AGAINST NEUROGLIOMA CELLS U251 GROWTH AND ITS MECHANISM
por: Xin, ShiMeng, et al.
Publicado: (2016)